SCHEMBL3105471

SCHEMBL3105471

Fc1ccc(-c2cc(-n3c4ccccc4c4ccccc43)ccn2)c(F)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 4/20 0.44
MAPK13 O15264 3/20 0.44
MAPK12 P53778 3/20 0.44
MAPK11 Q15759 3/20 0.44
FAAH O00519 1/20 0.43
KMO O15229 2/20 0.40
ADORA2A P29274 1/20 0.40
ADORA1 P30542 1/20 0.40
TGFBR1 P36897 1/20 0.39
EGFR P00533 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.38
KDM4E B2RXH2 1/20 0.38
ATM Q13315 1/20 0.38
MEN1 O00255 1/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
KMT2A Q03164 1/20 0.37
CASP3 P42574 1/20 0.37
SENP8 Q96LD8 1/20 0.37
SENP7 Q9BQF6 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3105279 0.82 KDM4E (0.39) MAPK14MAPK13MAPK12MAPK11TGFBR1
SCHEMBL3102322 0.82 TGFBR1 (0.43) MAPK14TGFBR1L3MBTL1KDM4EATM
SCHEMBL15469063 0.81 KDM4E (0.52) L3MBTL1KDM4EATMMCL1CYP1A2
SCHEMBL14280366 0.80 TRPA1 (0.45) MAPK14MAPK13MAPK12MAPK11FAAH
SCHEMBL13754820 0.79 GRM5 (0.40) MAPK14MAPK13MAPK12MAPK11TGFBR1
SCHEMBL13109071 0.78 FAAH (0.41) FAAHKMOADORA2AADORA1EGFR
SCHEMBL13109073 0.78 KDM4E (0.33) TGFBR1L3MBTL1KDM4EATM
SCHEMBL25880785 0.78 PRKDC (0.34) MAPK14MAPK13MAPK12MAPK11TGFBR1
SCHEMBL4864316 0.77 FAAH (0.46) MAPK14MAPK13MAPK12MAPK11FAAH
SCHEMBL13754823 0.77 GRM5 (0.38) MAPK14MAPK13MAPK12MAPK11TGFBR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8232549-B2 Iridium complex containing carbazole-substituted pyridine and phenyl derivatives as main ligand and organic light-emitting diodes containing the same INKTEC CO., LTD (KR) 2012-07-31 US disclosed
US-8232549-B2 Iridium complex containing carbazole-substituted pyridine and phenyl derivatives as main ligand and organic light-emitting diodes containing the same INKTEC CO., LTD (KR) 2012-07-31 US disclosed
US-8232549-B2 Iridium complex containing carbazole-substituted pyridine and phenyl derivatives as main ligand and organic light-emitting diodes containing the same INKTEC CO., LTD (KR) 2012-07-31 US disclosed
US-20100270540-A1 Iridium Complex Containing Carbazole-Substituted Pyridine and Phenyl Derivatives as Main Ligand and Organic Light-Emitting Diodes Containing the Same INKTEC CO., LTD. (KR) 2010-10-28 US disclosed
US-20100270540-A1 Iridium Complex Containing Carbazole-Substituted Pyridine and Phenyl Derivatives as Main Ligand and Organic Light-Emitting Diodes Containing the Same INKTEC CO., LTD. (KR) 2010-10-28 US disclosed
US-20100270540-A1 Iridium Complex Containing Carbazole-Substituted Pyridine and Phenyl Derivatives as Main Ligand and Organic Light-Emitting Diodes Containing the Same INKTEC CO., LTD. (KR) 2010-10-28 US disclosed
US-7816016-B1 hexacoordinated Indium complex made of ligand 1,1-bis(trifluoromethyl)-2-(diphenylphosphino)-ethanol and bis-cyclometallated Ir 2-(2,4-difluoro-3-perfluoroisopropyl-phenyl)-4-carbazolyl-pyridine E. I. DU PONT DE NEMOURS AND COMPANY (US) 2010-10-19 US disclosed
US-7816016-B1 hexacoordinated Indium complex made of ligand 1,1-bis(trifluoromethyl)-2-(diphenylphosphino)-ethanol and bis-cyclometallated Ir 2-(2,4-difluoro-3-perfluoroisopropyl-phenyl)-4-carbazolyl-pyridine E. I. DU PONT DE NEMOURS AND COMPANY (US) 2010-10-19 US disclosed
WO-2009072821-A2 IRIDIUM COMPLEX CONTAINING CARBAZOLE-SUBSTITUTED PYRIDINE AND PHENYL DERIVATIVES AS MAIN LIGAND AND ORGANIC LIGHT-EMITTING DIODES CONTAINING THE SAME INKTEC CO., LTD. (KR) 2009-06-11 WO disclosed
WO-2009072821-A2 IRIDIUM COMPLEX CONTAINING CARBAZOLE-SUBSTITUTED PYRIDINE AND PHENYL DERIVATIVES AS MAIN LIGAND AND ORGANIC LIGHT-EMITTING DIODES CONTAINING THE SAME INKTEC CO., LTD. (KR) 2009-06-11 WO disclosed
US-7320835-B2 Phosphorescent material E. I. DU PONT DE NEMOURS AND COMPANY (US) 2008-01-22 US disclosed
US-7320835-B2 Phosphorescent material E. I. DU PONT DE NEMOURS AND COMPANY (US) 2008-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100270540-A1 Iridium Complex Containing Carbazole-Substituted Pyridine and Phenyl Derivatives as Main Ligand and Organic Light-Emitting Diodes Containing the Same PDCD5, MAP1LC3B, MAP1LC3A MAPK14 2585/4885MAPK13 3871/4885MAPK12 3347/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.